Titan Spine Inc. is a medical technology company specializing in the design and manufacture of interbody fusion devices for the spine. Founded in either 2005 or 2006, the company was headquartered in Mequon, Wisconsin. Prior to its acquisition, Titan Spine was a privately held entity, reporting approximately $63 million in revenue in 2017 and employing around 85-110 individuals.
The company's core products include titanium interbody fusion devices, such as its Endoskeleton® line and nanoLOCK® platform. These implants feature proprietary textured surfaces designed to promote natural bone growth and enhance fusion rates in spinal surgery. These devices function as spacers inserted between vertebrae during spinal fusion procedures to alleviate nerve pressure and stabilize the spine.
Titan Spine's patent litigation posture, based on the provided data, indicates it operates as a defendant in patent disputes. The company has 1 tracked case, in which it appears solely as a defendant and has no record as a plaintiff. This profile is consistent with an operating company defending against patent infringement claims.
A significant event in the company's history is its acquisition by Medtronic plc (NYSE: MDT), a global medical technology leader, which was finalized in June 2019. This acquisition integrated Titan Spine's portfolio of surface-enhanced titanium interbody fusion devices into Medtronic's broader spinal surgery solutions. The tracked case, "Moskowitz Family LLC v. Medtronic Sofamor Danek Inc. et al.," lists Titan Spine Inc. as a defendant in the Minnesota District Court, likely reflecting its status as a Medtronic subsidiary.